Abstract
We developed a rapid single nucleotide polymorphism (SNP) detection system named smart amplification process version 2 (SMAP 2). Because DNA amplification only occurred with a perfect primer match, amplification alone was sufficient to identify the target allele. To achieve the requisite fidelity to support this claim, we used two new and complementary approaches to suppress exponential background DNA amplification that resulted from mispriming events. SMAP 2 is isothermal and achieved SNP detection from whole human blood in 30 min when performed with a new DNA polymerase that was cloned and isolated from Alicyclobacillus acidocaldarius (Aac pol). Furthermore, to assist the scientific community in configuring SMAP 2 assays, we developed software specific for SMAP 2 primer design. With these new tools, a high-precision and rapid DNA amplification technology becomes available to aid in pharmacogenomic research and molecular-diagnostics applications.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Development of non-electrically controlled SalivaDirect LAMP (NEC-SD-LAMP), a new nonelectrical infectious disease testing method
Scientific Reports Open Access 21 July 2023
-
SEB genotyping: SmartAmp-Eprimer binary code genotyping for complex, highly variable targets applied to HBV
BMC Infectious Diseases Open Access 03 June 2022
-
Interaction between TP53 and XRCC1 increases susceptibility to cervical cancer development: a case control study
BMC Cancer Open Access 07 January 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout






References
Venter, J.C. et al. The sequence of the human genome. Science 291, 1304–1351 (2001).
Lander, E.S. et al. Initial sequencing and analysis of the human genome. Nature 409, 860–921 (2001).
Miller, R.D. et al. High-density single-nucleotide polymorphism maps of the human genome. Genomics 86, 117–126 (2005).
Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 431, 931–945 (2004).
Sachidanandam, R. et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409, 928–933 (2001).
Hardenbol, P. et al. Multiplexed genotyping with sequence-tagged molecular inversion probes. Nat. Biotechnol. 21, 673–678 (2003).
Kennedy, G.C. et al. Large-scale genotyping of complex DNA. Nat. Biotechnol. 21, 1233–1237 (2003).
Lyamichev, V. et al. Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nat. Biotechnol. 17, 292–296 (1999).
Shen, R. et al. High-throughput SNP genotyping on universal bead arrays. Mutat. Res. 573, 70–82 (2005).
Biswas, I. & Hsieh, P. Identification and characterization of a thermostable MutS homolog from Thermus aquaticus. J. Biol. Chem. 271, 5040–5048 (1996).
Iwasaki, M. & Yonokawa, T. Validation of the loop-mediated isothermal amplification method for single nucleotide polymorphism genotyping with whole blood. Genome Lett. 2, 119–126 (2003).
Mentucci, D. et al. Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance. Diabetes 51, 880–883 (2002).
Harada, S., Okubo, T., Tsutsumi, M., Takase, S. & Muramatsu, T. Investigation of genetic risk factors associated with alcoholism. Alcohol. Clin. Exp. Res. 20, 293A–296A (1996).
Harada, S. & Zhang, S. New strategy for detection of ALDH2 mutant. Alcohol Alcohol. (Suppl.) 1A, 11–13 (1993).
de Morais, S.M. et al. The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J. Biol. Chem. 269, 15419–15422 (1994).
Rozen, S. & Skaletsky, H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132, 365–386 (2000).
Walston, J. et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N. Engl. J. Med. 333, 343–347 (1995).
Berard, C., Cazalis, M.A., Leissner, P. & Mougin, B. DNA nucleic acid sequence-based amplification-based genotyping for polymorphism analysis. Biotechniques 37, 680–686 (2004).
Pickering, J. et al. Integration of DNA ligation and rolling circle amplification for the homogeneous, end-point detection of single nucleotide polymorphisms. Nucleic Acids Res. 30, e60 (2002).
Wang, S.S., Thornton, K., Kuhn, A.M., Nadeau, J.G. & Hellyer, T.J. Homogeneous real-time detection of single-nucleotide polymorphisms by strand displacement amplification on the BD ProbeTec ET system. Clin. Chem. 49, 1599–1607 (2003).
Acknowledgements
We thank A. Wada for support and encouragement, T. Ishikawa (Tokyo Institute of Technology) for his constructive discussion about the application of this technology and future prospects, M. Matsunaga, J. Nakashima, M. Matsushita and S. Uno for technical assistance. We acknowledge K. Nakano (NTT Software Corporation) for assistance in web support and software design. We also thank H. Daub and M. Nishikawa (RIKEN) for their editorial and coordination efforts. This study was mainly supported by the research grant for the RIKEN Genome Exploration Research Project from the Ministry of Education, Culture, Sports, Science and Technology of the Japan (MEXT) to Y. Hayashizaki, and RIKEN “Research Collaborations with Industry” Program to K. Shibata. S. Kuramitsu is supported by the Research Grant for National Project on Protein Structure and Functional Analysis from MEXT.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Some of the authors of this manuscript are employed by or affiliated with the corporations K.K. DNAFORM and Wakunaga Pharmaceutical Co. Ltd. Y.M., Y.K., T.K. and C.K. are employed by K.K. DNAFORM. T.M. and T.O. are employed by Wakunaga Pharmaceutical Co., Ltd.
It is the intention of K.K. DNAFORM to commercialize the technology described in this manuscript for research and diagnostic purposes.
Supplementary information
Supplementary Fig. 1
Comparison of background amplification pathways of SMAP ver.2 and LAMP. (PDF 829 kb)
Supplementary Fig. 2
SMAP ver.2 amplification of the type 2 iodothyronine deiodinase (DIO2) gene. (PDF 1397 kb)
Supplementary Fig. 3
Amplification time course of DIO2 allele by SMAP and LAMP methods. (PDF 1245 kb)
Supplementary Fig. 4
Electrophoresis photograph of SMAP and LAMP amplification products. (PDF 988 kb)
Supplementary Fig. 5
SMAP ver.2 amplification of the human b3 adrenergic receptor (ADRB3) gene. (PDF 1126 kb)
Supplementary Fig. 6
Sensitivity determination of SMAP ver.2. (PDF 1369 kb)
Rights and permissions
About this article
Cite this article
Mitani, Y., Lezhava, A., Kawai, Y. et al. Rapid SNP diagnostics using asymmetric isothermal amplification and a new mismatch-suppression technology. Nat Methods 4, 257–262 (2007). https://doi.org/10.1038/nmeth1007
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nmeth1007
This article is cited by
-
Development of non-electrically controlled SalivaDirect LAMP (NEC-SD-LAMP), a new nonelectrical infectious disease testing method
Scientific Reports (2023)
-
SEB genotyping: SmartAmp-Eprimer binary code genotyping for complex, highly variable targets applied to HBV
BMC Infectious Diseases (2022)
-
Interaction between TP53 and XRCC1 increases susceptibility to cervical cancer development: a case control study
BMC Cancer (2019)
-
Unusual isothermal multimerization and amplification by the strand-displacing DNA polymerases with reverse transcription activities
Scientific Reports (2017)
-
Establishment of a Quick and Highly Accurate Breath Test for ALDH2 Genotyping
Clinical and Translational Gastroenterology (2017)